Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2012

01-04-2012 | Original Article

Prospective Assessment of Risk of Bacteremia Following Colorectal Stent Placement

Authors: Yeon Joo Chun, Na Ri Yoon, Jae Myung Park, Chul-Hyun Lim, Yu Kyung Cho, In Seok Lee, Sang Woo Kim, Myung-Gyu Choi, Kyu Yong Choi, In-Sik Chung

Published in: Digestive Diseases and Sciences | Issue 4/2012

Login to get access

Abstract

Background

Colorectal stent insertion is an invasive endoscopic procedure. However, there are no reports regarding the incidence of bacteremia with colorectal stent.

Objective

This study was to evaluate the risk of bacteremia and infectious complications after stent insertion for colorectal obstruction.

Methods

Patients who underwent colorectal stent insertion were enrolled consecutively. Blood cultures were obtained before colorectal stent insertion and at 30 min after the procedure. Patients were monitored for 48 h after colorectal stent insertion to detect the development of infectious complications. Procedural data collected included location of obstruction, degree of bowel preparation, obstructive symptoms, and the time required for the procedure.

Results

Of 64 patients undergoing colorectal stent, four (6.3%) had a positive post-stent blood culture. All patients, including those with positive cultures, remained asymptomatic during the 48 h after the procedure. Site of obstruction, degree of bowel preparation, age, and underlying disease were not different between the two groups. Development of bacteremia was associated with long procedure time (p < 0.05).

Conclusions

Colorectal stent insertion does not induce significant bacteremia in patients with colorectal obstruction. These findings suggest that the routine use of prophylactic antibiotics may not be necessary in colorectal stent insertion.
Literature
1.
go back to reference Nelson DB. Infectious disease complications of GI endoscopy: part I, endogenous infections. Gastrointest Endosc. 2003;57:546–556.PubMedCrossRef Nelson DB. Infectious disease complications of GI endoscopy: part I, endogenous infections. Gastrointest Endosc. 2003;57:546–556.PubMedCrossRef
2.
go back to reference American Society for Gastrointestinal Endoscopy. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008;67:791–798.CrossRef American Society for Gastrointestinal Endoscopy. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008;67:791–798.CrossRef
3.
go back to reference Shull HJ Jr, Greene BM, Allen SD, et al. Bacteremia with upper gastrointestinal endoscopy. Ann Intern Med. 1975;83:212–214.PubMed Shull HJ Jr, Greene BM, Allen SD, et al. Bacteremia with upper gastrointestinal endoscopy. Ann Intern Med. 1975;83:212–214.PubMed
4.
go back to reference Mellow MH, Lewis RJ. Endoscopy-related bacteremia. Incidence of positive blood cultures after endoscopy of upper gastrointestinal tract. Arch Intern Med. 1976;136:667–669.PubMedCrossRef Mellow MH, Lewis RJ. Endoscopy-related bacteremia. Incidence of positive blood cultures after endoscopy of upper gastrointestinal tract. Arch Intern Med. 1976;136:667–669.PubMedCrossRef
5.
go back to reference Baltch AL, Buhac I, Agrawal A, et al. Bacteremia after upper gastrointestinal endoscopy. Arch Intern Med. 1977;137:594–597.PubMedCrossRef Baltch AL, Buhac I, Agrawal A, et al. Bacteremia after upper gastrointestinal endoscopy. Arch Intern Med. 1977;137:594–597.PubMedCrossRef
6.
go back to reference Kirk A, Graham-Brown R, Perinpanayagam RM, et al. Bacteraemia and upper gastrointestinal fibre-endoscopy. J R Soc Med. 1979;72:409–411.PubMed Kirk A, Graham-Brown R, Perinpanayagam RM, et al. Bacteraemia and upper gastrointestinal fibre-endoscopy. J R Soc Med. 1979;72:409–411.PubMed
7.
go back to reference Kumar S, Abcarian H, Prasad ML, et al. Bacteremia associated with lower gastrointestinal endoscopy, fact or fiction? Dis Colon Rectum. 1982;25:131–134.PubMedCrossRef Kumar S, Abcarian H, Prasad ML, et al. Bacteremia associated with lower gastrointestinal endoscopy, fact or fiction? Dis Colon Rectum. 1982;25:131–134.PubMedCrossRef
8.
go back to reference Low DE, Shoenut JP, Kennedy JK, et al. Prospective assessment of risk of bacteremia with colonoscopy and polypectomy. Dig Dis Sci. 1987;32:1239–1243.PubMedCrossRef Low DE, Shoenut JP, Kennedy JK, et al. Prospective assessment of risk of bacteremia with colonoscopy and polypectomy. Dig Dis Sci. 1987;32:1239–1243.PubMedCrossRef
9.
go back to reference Motte S, Deviere J, Dumonceau JM, et al. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology. 1991;101:1374–1381.PubMed Motte S, Deviere J, Dumonceau JM, et al. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology. 1991;101:1374–1381.PubMed
10.
go back to reference Deviere J, Motte S, Dumonceau JM, et al. Septicemia after endoscopic retrograde cholangiopancreatography. Endoscopy. 1990;22:72–75.PubMedCrossRef Deviere J, Motte S, Dumonceau JM, et al. Septicemia after endoscopic retrograde cholangiopancreatography. Endoscopy. 1990;22:72–75.PubMedCrossRef
11.
go back to reference Kolars JC, Allen MO, Ansel H, et al. Pancreatic pseudocysts: clinical and endoscopic experience. Am J Gastroenterol. 1989;84:259–264.PubMed Kolars JC, Allen MO, Ansel H, et al. Pancreatic pseudocysts: clinical and endoscopic experience. Am J Gastroenterol. 1989;84:259–264.PubMed
12.
go back to reference Sharma VK, Howden CW. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am J Gastroenterol. 2000;95:3133–3136.PubMedCrossRef Sharma VK, Howden CW. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am J Gastroenterol. 2000;95:3133–3136.PubMedCrossRef
13.
go back to reference Meisner S, Hensler M, Knop FK, et al. Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center. Dis Colon Rectum. 2004;47:444–450.PubMedCrossRef Meisner S, Hensler M, Knop FK, et al. Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center. Dis Colon Rectum. 2004;47:444–450.PubMedCrossRef
14.
go back to reference Sebastian S, Johnston S, Geoghegan T, et al. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol. 2004;99:2051–2057.PubMedCrossRef Sebastian S, Johnston S, Geoghegan T, et al. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol. 2004;99:2051–2057.PubMedCrossRef
15.
go back to reference Nelson DB, Sanderson SJ, Azar MM. Bacteremia with esophageal dilation. Gastrointest Endosc. 1998;48:563–567.PubMedCrossRef Nelson DB, Sanderson SJ, Azar MM. Bacteremia with esophageal dilation. Gastrointest Endosc. 1998;48:563–567.PubMedCrossRef
16.
go back to reference Levy MJ, Norton ID, Wiersema MJ, et al. Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS guided FNA. Gastrointest Endosc. 2003;57:672–678.PubMedCrossRef Levy MJ, Norton ID, Wiersema MJ, et al. Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS guided FNA. Gastrointest Endosc. 2003;57:672–678.PubMedCrossRef
17.
go back to reference Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2006;63:S16–S28.PubMedCrossRef Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2006;63:S16–S28.PubMedCrossRef
18.
go back to reference Weinstein MP, Reller LB, Murphy JR, et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis. 1983;5:35–53.PubMedCrossRef Weinstein MP, Reller LB, Murphy JR, et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis. 1983;5:35–53.PubMedCrossRef
19.
go back to reference MacGregor RR, Beaty HN. Evaluation of positive blood cultures. Guidelines for early differentiation of contaminated from valid positive cultures. Arch Intern Med. 1972;130:84–87.PubMedCrossRef MacGregor RR, Beaty HN. Evaluation of positive blood cultures. Guidelines for early differentiation of contaminated from valid positive cultures. Arch Intern Med. 1972;130:84–87.PubMedCrossRef
20.
go back to reference Levy MJ, Norton ID, Clain JE, et al. Prospective study of bacteremia and complications with EUS FNA of rectal and perirectal lesions. Clin Gastroenterol Hepatol. 2007;5:684–689.PubMedCrossRef Levy MJ, Norton ID, Clain JE, et al. Prospective study of bacteremia and complications with EUS FNA of rectal and perirectal lesions. Clin Gastroenterol Hepatol. 2007;5:684–689.PubMedCrossRef
Metadata
Title
Prospective Assessment of Risk of Bacteremia Following Colorectal Stent Placement
Authors
Yeon Joo Chun
Na Ri Yoon
Jae Myung Park
Chul-Hyun Lim
Yu Kyung Cho
In Seok Lee
Sang Woo Kim
Myung-Gyu Choi
Kyu Yong Choi
In-Sik Chung
Publication date
01-04-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1962-x

Other articles of this Issue 4/2012

Digestive Diseases and Sciences 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine